Literature DB >> 16396795

Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period.

Kaija Lammintausta1, Outi Kortekangas-Savolainen.   

Abstract

The aim of this study was to analyse the usefulness of oral challenge test with different drugs in confirming cutaneous adverse drug reactions in routine clinical practice. During the years 1975-2000 a total of 1,001 challenges were carried out in 784 patients. Patients with serious drug reactions were excluded and those with positive skin test reactions were challenged only in dubious cases. Of 1,001 challenges, 136 (13%) patients developed a positive challenge reaction. Antimicrobial drugs were most commonly suspected, accounting for 67% of challenges and 66% of the positive reactions. Exanthema was the most common skin reaction (72%), followed by fixed drug eruption (16%) and urticaria (12%). One serious challenge reaction with salazosulfapyridine was seen. We conclude that the challenge test is most useful as a tolerance test or to exclude drug hypersensitivity. It may be useful to complete studies of adverse drug reactions in patients with a history of exanthema, if other diagnostic methods are not available or if other diagnostic tests yield negative results. Out-patient protocol can be used in most cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16396795     DOI: 10.1080/00015550510042859

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  7 in total

Review 1.  Controversies in drug allergy: Testing for delayed reactions.

Authors:  Elizabeth J Phillips; Paul Bigliardi; Andreas J Bircher; Ana Broyles; Yoon-Seok Chang; Wen-Hung Chung; Rannakoe Lehloenya; Maja Mockenhaupt; Jonny Peter; Munir Pirmohamed; Jean-Claude Roujeau; Neil H Shear; Luciana Kase Tanno; Jason Trubiano; Rocco Valluzzi; Annick Barbaud
Journal:  J Allergy Clin Immunol       Date:  2018-12-17       Impact factor: 10.793

2.  Predictive value of the lymphocyte toxicity assay in the diagnosis of drug hypersensitivity syndrome.

Authors:  Abdelbaset A Elzagallaai; Zahra Jahedmotlagh; Blanca R Del Pozzo-Magaña; Sandra R Knowles; Asuri N Prasad; Neil H Shear; Michael J Rieder; Gideon Koren
Journal:  Mol Diagn Ther       Date:  2010-10-01       Impact factor: 4.074

Review 3.  Evaluation of antibiotic allergy: the role of skin tests and drug challenges.

Authors:  Roland Solensky; David A Khan
Journal:  Curr Allergy Asthma Rep       Date:  2014-09       Impact factor: 4.806

Review 4.  Road Less Traveled: Drug Hypersensitivity to Fluoroquinolones, Vancomycin, Tetracyclines, and Macrolides.

Authors:  Linda J Zhu; Anne Y Liu; Priscilla H Wong; Anna Chen Arroyo
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-29       Impact factor: 10.817

5.  Fixed drug eruption resulting from fluconazole use: a case report.

Authors:  Mahkam Tavallaee; Mahnaz Mahmoudi Rad
Journal:  J Med Case Rep       Date:  2009-07-06

6.  Fixed drug eruption due to clarithromycin.

Authors:  Santoshi Balkrishna Malkarnekar; L Naveen
Journal:  J Res Pharm Pract       Date:  2013-10

7.  Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case report.

Authors:  Calypse Asangbe Ngwasiri; Martin Hongieh Abanda; Leopold Ndemnge Aminde
Journal:  J Med Case Rep       Date:  2018-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.